Home › NDC Lookup › RxCUI directory › RxCUI 1740900

Mitomycin 20 MG Injection — RxCUI 1740900

RxNorm drug concept · Semantic clinical drug
RxCUI 1740900 Semantic clinical drug · SCD ● Current RxNorm concept 29 FDA products 29 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1740900
Official nameMitomycin 20 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped29
Package NDCs mapped29
Reported Medicaid activity (SDUD)48 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mitomycin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The injection form, sold as Mitomycin or Mutamycin, is used with other chemotherapy drugs for stomach or pancreatic cancer that has spread. It can also be used for palliative care...
  • The injection goes into a vein through an IV catheter. A healthcare professional with chemotherapy experience gives it. Treatments are spaced several weeks apart, once your blood c...
  • The most common is low blood counts, which is why you will have regular blood tests. Nausea, vomiting, and tiredness can also occur. Your team will adjust the plan if your counts d...
  • Call for fever, chills, or other signs of infection. Also call for unusual bleeding or bruising, much less urine, or swelling. Pain, redness, or skin damage where the IV was placed...
📖 Read our full Mitomycin guide →

🕸️ Concept Web — How Mitomycin 20 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mitomycin 20 MG Injection RxCUI 1740900

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mitomycin 632
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mutamycin 204298
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mitomycin Injection 1740893
    • Mitomycin Injectable Product 1165372
    • Mitomycin Injection [Mutamycin] 1812478
    • Mutamycin Injectable Product 1812479
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mitomycin 20 MG SCDC · 1740899
  • Mitomycin Injection SCDF · 1740893
  • Mitomycin Injectable Product SCDG · 1165372

Brand-Name Concepts

  • Mitomycin 20 MG Injection [Mutamycin] SBD · 1812480
  • Mitomycin 20 MG [Mutamycin] SBDC · 1812477
  • Mitomycin Injection [Mutamycin] SBDF · 1812478
  • Mutamycin Injectable Product SBDG · 1812479
  • Mutamycin BN · 204298

📦 FDA Products & Package NDCs

29 products · 29 package NDCs
29 package NDCs map to RxCUI 1740900 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9135-01 1 VIAL in 1 BOX (0143-9135-01) / 1 INJECTION, POWDER, LYOPH... Mitomycin Hikma Pharmaceuticals USA Inc. 2022-10-01
00143-9136-01 1 VIAL in 1 BOX (0143-9136-01) / 1 INJECTION, POWDER, LYOPH... Mitomycin Hikma Pharmaceuticals USA Inc. 2022-10-01
00143-9279-01 1 VIAL in 1 BOX, UNIT-DOSE (0143-9279-01) / 40 mL in 1 VIAL Mitomycin Hikma Pharmaceuticals USA Inc. 1996-05-01
00143-9280-01 1 VIAL in 1 BOX, UNIT-DOSE (0143-9280-01) / 80 mL in 1 VIAL Mitomycin Hikma Pharmaceuticals USA Inc. 1999-09-01
16729-0108-11 1 VIAL in 1 BOX, UNIT-DOSE (16729-108-11) / 40 mL in 1 VIAL Mitomycin Accord Healthcare, Inc. 2009-06-10
16729-0115-05 1 VIAL in 1 CARTON (16729-115-05) / 10 mL in 1 VIAL Mitomycin Accord Healthcare, Inc. 2009-06-18
16729-0116-38 1 VIAL in 1 BOX, UNIT-DOSE (16729-116-38) / 80 mL in 1 VIAL Mitomycin Accord Healthcare, Inc. 2011-03-11
25021-0250-20 1 VIAL in 1 CARTON (25021-250-20) / 10 mL in 1 VIAL Mitomycin Sagent Pharmaceuticals 2023-06-15
25021-0251-50 1 VIAL in 1 CARTON (25021-251-50) / 40 mL in 1 VIAL Mitomycin Sagent Pharmaceuticals 2023-06-15
55150-0450-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-450-01) / 10 mL in 1... MITOMYCIN Eugia US LLC 2023-10-30
55150-0451-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-451-01) / 40 mL in 1... MITOMYCIN Eugia US LLC 2023-10-30
55150-0452-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-452-01) / 80 mL in 1... MITOMYCIN Eugia US LLC 2023-10-30
65219-0564-20 1 VIAL in 1 CARTON (65219-564-20) / 10 mL in 1 VIAL MITOMYCIN Fresenius Kabi USA, LLC 2023-01-15
65219-0566-20 1 VIAL in 1 CARTON (65219-566-20) / 40 mL in 1 VIAL MITOMYCIN Fresenius Kabi USA, LLC 2023-01-15
68001-0389-36 1 VIAL in 1 CARTON (68001-389-36) / 10 mL in 1 VIAL (68001-... Mitomycin BluePoint Laboratories 2019-05-14
68001-0390-77 1 VIAL in 1 BOX, UNIT-DOSE (68001-390-77) / 40 mL in 1 VIAL... Mitomycin BluePoint Laboratories 2019-05-14
68001-0391-79 1 VIAL in 1 BOX, UNIT-DOSE (68001-391-79) / 80 mL in 1 VIAL... Mitomycin BluePoint Laboratories 2019-05-14
68001-0615-36 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-615-36) / 10 mL in 1... MITOMYCIN BluePoint Laboratories 2024-07-08
68001-0616-77 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-616-77) / 40 mL in 1... MITOMYCIN BluePoint Laboratories 2024-06-24
68001-0617-79 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-617-79) / 80 mL in 1... MITOMYCIN BluePoint Laboratories 2024-07-11
68083-0483-01 1 VIAL in 1 CARTON (68083-483-01) / 10 mL in 1 VIAL MITOMYCIN Gland Pharma Limited 2021-10-20
68083-0484-01 1 VIAL in 1 CARTON (68083-484-01) / 40 mL in 1 VIAL MITOMYCIN Gland Pharma Limited 2021-10-20
69448-0001-05 1 VIAL in 1 CARTON (69448-001-05) / 10 mL in 1 VIAL MUTAMYCIN Accord BioPharma Inc. 2017-07-25
69448-0003-38 1 VIAL in 1 BOX, UNIT-DOSE (69448-003-38) / 80 mL in 1 VIAL MUTAMYCIN Accord BioPharma Inc. 2017-07-25
71288-0137-20 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-137-20) / 10 mL in 1... MITOMYCIN Meitheal Pharmaceuticals Inc. 2022-09-08
71288-0138-50 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-138-50) / 40 mL in 1... MITOMYCIN Meitheal Pharmaceuticals Inc. 2022-09-08
72819-0152-05 1 VIAL in 1 CARTON (72819-152-05) / 10 mL in 1 VIAL Mitomycin Archis Pharma LLC 2022-04-25
72819-0153-02 1 VIAL in 1 CARTON (72819-153-02) / 40 mL in 1 VIAL Mitomycin Archis Pharma LLC 2022-04-25
72819-0154-04 1 VIAL in 1 CARTON (72819-154-04) / 80 mL in 1 VIAL Mitomycin Archis Pharma LLC 2022-04-25
Observed labelers: BluePoint Laboratories (6) · Hikma Pharmaceuticals USA Inc. (4) · Accord Healthcare, Inc. (3) · Archis Pharma LLC (3) · Eugia US LLC (3) · Accord BioPharma Inc. (2) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9280 Mitomycin injection 22 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.